Almirall SA (LBTSF) Stock Price, Trades & News

Almirall SA is a skin-health focused pharmaceutical company based in Barcelona and the parent company of a group engaged in the purchase, manufacture, storage, marketing, and mediation in the sale of pharmaceutical specialities and products, as well as related raw materials. The Group applies science to provide medical solutions focused on skin health diseases and partners with healthcare professionals, and its activities also include cosmetics; chemical, biotechnological and diagnostic products for human, veterinary, agrochemical and food use; instruments and accessories for the chemical, pharmaceutical and clinical industry; and research on active chemical and pharmaceutical ingredients and products.

Financial Strength

8/10

Name	Current	Vs Industry
Cash-To-Debt	1.09
Equity-to-Asset	0.65
Debt-to-Equity	0.19
Debt-to-EBITDA	0.96
Interest Coverage	4.34
Piotroski F-Score	7/9	0 1 2 3 4 5 6 7 8 9
Altman Z-Score	2.73	Distress Grey Safe
Beneish M-Score	-2.71	Manipulator Not Manipulator
WACC vs ROIC		WACC ROIC

Growth Rank

8/10

	Name	Current	Vs Industry		Vs History
	3-Year Revenue Growth Rate	6.4
	3-Year EBITDA Growth Rate	11.3
	3-Year EPS without NRI Growth Rate	15
	3-Year FCF Growth Rate	-3.5
	3-Year Book Growth Rate	-1.6
	Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank	58.31
	Future 3-5Y Total Revenue Growth Rate Estimate	10.25

Momentum Rank

5/10

	Name	Current	Vs Industry		Vs History
	9-Day RSI	16.68
	14-Day RSI	51.29
	6-1 Month Momentum %	-0.78
	12-1 Month Momentum %	70.37

Liquidity Ratio

	Name	Current	Vs Industry		Vs History
	Current Ratio	2.32
	Quick Ratio	1.73
	Cash Ratio	1.03
	Days Inventory	158.78
	Days Sales Outstanding	41.3
	Days Payable	169.7

Dividend & Buy Back

	Name	Current	Vs Industry		Vs History
	Dividend Payout Ratio	0.8
	3-Year Dividend Growth Rate	-0.4
	3-Year Average Share Buyback Ratio	-5.8
	Shareholder Yield %	3.04

Profitability Rank

6/10

	Name	Current	Vs Industry		Vs History
	Gross Margin %	69.76
	Operating Margin %	6.8
	Net Margin %	3.81
	EBITDA Margin %	21.73
	FCF Margin %	3.65
	OCF Margin %	14.27
	ROE %	3.52
	ROA %	2.23
	ROIC %	3.09
	3-Year ROIIC %	35.87
	ROC (Joel Greenblatt) %	42.21
	ROCE %	5.16
	Years of Profitability over Past 10-Year	7

GF Value Rank

10/10

	Name	Current	Vs Industry		Vs History
	PE Ratio	46.72
	Forward PE Ratio	26.6
	PE Ratio without NRI	49.82
	Price-to-Owner-Earnings	26.68
	PS Ratio	1.78
	PB Ratio	1.6
	Price-to-Tangible-Book	9.25
	Price-to-Free-Cash-Flow	47.31
	Price-to-Operating-Cash-Flow	12.37
	EV-to-EBIT	23.19
	EV-to-Forward-EBIT	25.09
	EV-to-EBITDA	8.12
	EV-to-Forward-EBITDA	11.4
	EV-to-Revenue	1.76
	EV-to-Forward-Revenue	2.04
	EV-to-FCF	49.13
	Price-to-GF-Value	0.91
	Price-to-Projected-FCF	1.55
	Price-to-Median-PS-Value	0.8
	Price-to-Peter-Lynch-Fair-Value	8.53
	Price-to-Graham-Number	4.53
	Earnings Yield (Greenblatt) %	4.31
	FCF Yield %	2.01
	Forward Rate of Return (Yacktman) %	7.76

GF Value™: $16.92

LBTSF

Warning Signs

Warning! GuruFocus detected 1 Severe warning sign with LBTSF. Try a 7-Day Free Trial to check it out.

Almirall SA Filings

10-K10-QForm 4Others

	Filing Date	Document Date	Form
No Filing Data

Almirall SA Stock Events

Financials Calendars

Event	Date	Price ($)
Third quarter earnings results for 2026	2026-11-09	In 136 days
Second quarter earnings results for 2026	2026-07-24	In 28 days
EUR 0.187000 Cash Dividend	2026-05-14	15.35 (+0.00%)
First quarter earnings results for 2026	2026-05-11	15.35 (+0.00%)
General meeting for 2026	2026-05-08 13:00	15.35 (+0.00%)
Annual report for 2025	2026-02-23	15.35 (+0.00%)
Fourth quarter earnings results for 2025	2026-02-23	15.35 (+0.00%)
44th Annual J.P. Morgan Healthcare Conference	2026-01-13	15.47 (+0.00%)
Third quarter earnings results for 2025	2025-11-10	13.36 (+0.00%)
Second quarter earnings results for 2025	2025-07-25	13.36 (+0.00%)

Show

Entries

Guru Commentaries on OTCPK:LBTSF

No articles.

Press Release

	Subject	Date
	Almirall achieves Core Net Sales growth of 5.1% to 436.6 MM Euros in H1	2022-07-25
	Almirall delivers good business performance in Q1 and reiterates full year 2022 guidance	2022-07-08
	Almirall delivers good business performance in Q1 and reiterates full year 2022 guidance	2022-06-28
	Almirall delivers good business performance in Q1 and reiterates full year 2022 guidance	2022-06-18
	Almirall delivers good business performance in Q1 and reiterates full year 2022 guidance	2022-06-08
	Almirall delivers good business performance in Q1 and reiterates full year 2022 guidance	2022-05-29
	Almirall delivers good business performance in Q1 and reiterates full year 2022 guidance	2022-05-19
	Almirall delivers good business performance in Q1 and reiterates full year 2022 guidance	2022-05-09
	Dr. Jorge Gallardo Ballart announces his intention to retire from his positions of President of the Board of Directors and Board member of Almirall	2022-02-21
	Almirall's Full-Year 2021 Results : Almirall delivers high end of the 2021 upgraded guidance with solid performance from growth drivers	2022-02-21

10/Page

Articles on Almirall SA

No articles.

Headlines

No news.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.